Earth Science Tech Builds Vertically Integrated Healthcare Platform for Dilution-Free Growth

Earth Science Tech Inc. leverages its compounding pharmacy subsidiaries and telemedicine to create a self-sustaining healthcare ecosystem that reduces liabilities and increases shareholder equity without dilution.

Philly Metrowire Staff
Healthcare
Earth Science Tech Builds Vertically Integrated Healthcare Platform for Dilution-Free Growth

Earth Science Tech Inc. (OTC: ETST) is advancing its strategy as a diversified holding company by integrating compounding pharmacy operations, telemedicine, and fulfillment services through its subsidiaries. The company's approach aims to reduce reliance on any single market segment while driving cash-flow-positive and dilution-free growth. In fiscal year 2026, Earth Science Tech reported a reduction in total liabilities and an increase in total assets, resulting in a net increase in shareholder equity.

The company's vertically integrated healthcare platform is built on the synergy of three specialized subsidiaries: RxCompoundStore (RxCS), Mister Meds, and Peaks Curative LLC. RxCS, a Miami-based licensed compounding pharmacy, produces both sterile and non-sterile medications. Mister Meds, based in Abilene, Texas, focuses on sterile medications and handles hazardous drugs. Together, these pharmacies compound custom medications that are supplied wholesale to independent clinics and directly to consumers through Peaks Curative LLC, which handles fulfillment and telemedicine services.

This dual-market operation—serving both wholesale and direct-to-consumer channels—allows Earth Science Tech to capture value across the healthcare supply chain. By controlling production, distribution, and patient access, the company reduces its dependence on any single revenue stream. The model also supports cash-flow-driven growth, as the subsidiaries generate revenue from both prescription fulfillment and telemedicine consultations.

Earth Science Tech's financial discipline is evident in its fiscal 2026 results, where it improved its balance sheet by decreasing liabilities and growing assets. The company has avoided equity dilution, a common challenge for small-cap healthcare firms, by relying on operational cash flows to fund expansion. This approach has strengthened shareholder equity without issuing new shares.

The compounding pharmacy market is experiencing growth due to increasing demand for personalized medications and the shift toward value-based care. Earth Science Tech's integrated model positions it to capitalize on these trends. For more information on Earth Science Tech's latest developments, visit the company's newsroom at https://ibn.fm/ETST.

InvestorWire, a specialized communications platform, distributed this press release. InvestorWire is part of the Dynamic Brand Portfolio @ IBN, which provides wire solutions, editorial syndication, and social media distribution. For more details, see the full terms of use at https://www.InvestorWire.com/Disclaimer.

Blockchain Registration

QR Code for Blockchain Registration